United States
Germany
Japan
United Kingdom
China
MAP2K1 Mutant (P124Q), Myc-DDK-tagged ORF clone of Homo sapiens mitogen-activated protein kinase kinase 1 (MAP2K1) as transfection-ready DNA
| Mutation | P124Q |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
Products
MAP2K1 Mutant (Y130N), Myc-DDK-tagged ORF clone of Homo sapiens mitogen-activated protein kinase kinase 1 (MAP2K1) as transfection-ready DNA
| Mutation | Y130N |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
MAP2K1 Mutant (F53S), Myc-DDK-tagged ORF clone of Homo sapiens mitogen-activated protein kinase kinase 1 (MAP2K1) as transfection-ready DNA
| Mutation | F53S |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
MAP2K1 Mutant (Y130C), Myc-DDK-tagged ORF clone of Homo sapiens mitogen-activated protein kinase kinase 1 (MAP2K1) as transfection-ready DNA
| Mutation | Y130C |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
MAP2K1 Mutant (E44G), Myc-DDK-tagged ORF clone of Homo sapiens mitogen-activated protein kinase kinase 1 (MAP2K1) as transfection-ready DNA
| Mutation | E44G |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
MAP2K1 Mutant (E203Q), Myc-DDK-tagged ORF clone of Homo sapiens mitogen-activated protein kinase kinase 1 (MAP2K1) as transfection-ready DNA
| Mutation | E203Q |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
MAP2K1 Mutant (T55P), Myc-DDK-tagged ORF clone of Homo sapiens mitogen-activated protein kinase kinase 1 (MAP2K1) as transfection-ready DNA
| Mutation | T55P |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
MAP2K1 - Human, 4 unique 29mer shRNA constructs in retroviral RFP vector, 5µg of each construct provided
| Format | Retroviral plasmids |
| Vector | pRFP-C-RS |
MAP2K1 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
| Format | Retroviral plasmids |
| Vector | pRS |
MAP2K1 CRISPRa kit - CRISPR gene activation of human mitogen-activated protein kinase kinase 1
| Format | 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug) |
MAP2K1 (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each
| Purity | HPLC purified |
| Number of Transfections | Approximately 330 transfections/2nmol in 24-well plate under optimized conditions (final conc. 10 nM). |
SR321446 is the updated version of SR303761.
MAP2K1 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
| Format | Lentiviral plasmids |
| Vector | pGFP-C-shLenti |
qPCR primer pairs and template standards against Homo sapiens gene MAP2K1
| Application | Plasmid of exact quantity for transcript copy number calculation |
qSTAR qPCR primer pairs against Homo sapiens gene MAP2K1
活动过滤器
优化搜索结果
Lentivirus
Tags
Mutants
Brands
Families
Pathways
- Acute myeloid leukemia (7)
- B cell receptor signaling pathway (7)
- Bladder cancer (7)
- Chemokine signaling pathway (7)
- Chronic myeloid leukemia (7)
- Colorectal cancer (7)
- Dorso-ventral axis formation (7)
- Endometrial cancer (7)
- ErbB signaling pathway (7)
- Fc epsilon RI signaling pathway (7)
- Fc gamma R-mediated phagocytosis (7)
- Focal adhesion (7)
- Gap junction (7)
- Glioma (7)
- GnRH signaling pathway (7)
- Insulin signaling pathway (7)
- Long-term depression (7)
- Long-term potentiation (7)
- MAPK signaling pathway (7)
- Melanogenesis (7)
- Melanoma (7)
- Natural killer cell mediated cytotoxicity (7)
- Neurotrophin signaling pathway (7)
- Non-small cell lung cancer (7)
- Oocyte meiosis (7)
- Pancreatic cancer (7)
- Pathways in cancer (7)
- Prion diseases (7)
- Progesterone-mediated oocyte maturation (7)
- Prostate cancer (7)
- Regulation of actin cytoskeleton (7)
- Renal cell carcinoma (7)
- T cell receptor signaling pathway (7)
- Thyroid cancer (7)
- Toll-like receptor signaling pathway (7)
- VEGF signaling pathway (7)
- Vascular smooth muscle contraction (7)
